Valuation: Zynex Inc.

Market Cap 38.29L 33.25L 31L 28.48L 53.86L 36Cr 54.45L 3.65Cr 1.43Cr 18Cr 1.44Cr 1.41Cr 60Cr P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 3.8Cr 3.3Cr 3.08Cr 2.83Cr 5.35Cr 361.67Cr 5.41Cr 36Cr 14Cr 180.8Cr 14Cr 14Cr 599.06Cr EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 16.93L
-1.26%-1.44%+21.76%+3.55% 21TCr
-0.43%-1.09%-0.29%-22.71% 14TCr
-2.77%+1.05%-24.36%+18.20% 13TCr
+0.65%+5.85%-54.34%-3.87% 7.02TCr
+0.30%+6.38%+11.14%+11.90% 5.11TCr
-0.28%+8.57%-15.66%-20.88% 5.01TCr
-0.54%-1.00%+21.16%+10.16% 3.95TCr
+5.10%+2.82%+38.22%+36.17% 3.68TCr
+1.18%+3.44%+102.78%+6.37% 2.99TCr
Average +0.24%+3.98%+11.16%+4.32% 8.46TCr
Weighted average by Cap. -0.53%+3.55%+3.46%+1.61%

Financials

2023 2024
Net sales 18Cr 16Cr 15Cr 14Cr 26Cr 1.75TCr 26Cr 175.93Cr 69Cr 876.46Cr 69Cr 68Cr 2.9TCr 19Cr 17Cr 16Cr 14Cr 27Cr 1.83TCr 27Cr 183.6Cr 72Cr 914.65Cr 72Cr 71Cr 3.03TCr
Net income 97.32L 84.5L 78.79L 72.38L 1.37Cr 93Cr 1.38Cr 9.29Cr 3.63Cr 46Cr 3.65Cr 3.57Cr 153.33Cr 29.94L 26L 24.24L 22.27L 42.11L 28Cr 42.57L 2.86Cr 1.12Cr 14Cr 1.12Cr 1.1Cr 47Cr
Net Debt 3.16Cr 2.74Cr 2.56Cr 2.35Cr 4.44Cr 300.48Cr 4.49Cr 30Cr 12Cr 150.21Cr 12Cr 12Cr 497.7Cr 3.42Cr 2.97Cr 2.77Cr 2.54Cr 4.81Cr 325.25Cr 4.86Cr 33Cr 13Cr 162.59Cr 13Cr 13Cr 538.73Cr
Logo Zynex Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
-